Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Medical Genetics

How Can Our Child Have Canavan Disease If We're Not Jewish?

At a Glance

Canavan disease is not limited to Ashkenazi Jewish families. A child can be affected when both parents, often healthy carriers, pass down disease-causing ASPA variants. Diagnostic testing can identify the family’s variants and guide testing for relatives and future pregnancies.

A diagnosis can be especially confusing when your family does not fit the group most often associated with the condition. It is important to know that nothing you or your partner did caused Canavan disease.

While Canavan disease is strongly associated with Ashkenazi Jewish ancestry, it is not exclusive to this group. Anyone of any ethnicity can carry a pathogenic variant (a disease-causing genetic change) in the ASPA gene, which provides instructions for aspartoacylase, an enzyme involved in breaking down N-acetylaspartic acid in the nervous system [1].

Because Canavan disease is an autosomal recessive genetic condition, a child will be born with it if both parents pass down a mutated copy of the gene, regardless of their ethnic or cultural background [1].

How Inheritance Works

Carriers of an ASPA gene variant are typically healthy and do not know they carry it. When both biological parents are carriers of a pathogenic ASPA variant, each pregnancy has a:

  • 25% chance that the child will have Canavan disease (inheriting the variant from both parents).
  • 50% chance that the child will be a healthy carrier like the parents (inheriting one variant).
  • 25% chance that the child will not have the disease and will not be a carrier.

These recurrence risks apply to all families facing this condition, and a genetic counselor can help you review options for any future pregnancies [1].

Understanding the Ashkenazi Jewish Connection

The misconception that Canavan disease only affects Jewish families stems from how frequently it occurs in that specific population. In the Ashkenazi Jewish community, the carrier frequency (the proportion of people who carry a variant) is much higher (about 1 in 40), and the overall prevalence (the estimated number of cases in the population) is approximately 1 in 6,400 to 1 in 13,500 [2]. Specific genetic changes, such as the p.Glu285Ala variant, are highly concentrated in this group [3].

Because of this higher concentration, carrier screening and public awareness have historically focused heavily on people of Ashkenazi Jewish descent.

Canavan Disease Across the Globe

Although the disease is less frequent overall outside of Ashkenazi communities, Canavan disease is diagnosed in families from many different ethnic backgrounds worldwide [4][5]. Researchers have documented cases in Arab, Iranian, Pakistani, Egyptian, and Indian families, among others [4][6][7].

Different populations often have their own specific variants of the ASPA gene. For example, in the Telugu Devanga Chettiar community of southern India, researchers identified a distinct genetic variant resulting in a carrier frequency of about 1 in 23 within that specific community [8][9].

Additionally, consanguinity (when parents are closely related by blood, such as cousins) can neutrally increase the chance that both parents carry the same rare genetic variant [4]. However, consanguinity does not cause the disease on its own, and the disease routinely occurs in completely unrelated parents who both happen to carry ASPA variants [1].

Genetic Testing for Diagnosis vs. Carrier Screening

It is important to understand the difference between diagnostic testing (finding out what is making a child sick) and carrier screening (checking if healthy adults carry a variant).

  • Targeted carrier panels are often designed to look primarily for the most common variants (such as those in the Ashkenazi Jewish population). If a relative takes a targeted panel, a rare variant specific to your family might be missed [10].
  • Diagnostic testing for a child usually involves full sequencing of the ASPA gene to look for any possible changes.

Sometimes, standard sequencing can miss complex genetic changes, like structural insertions (extra pieces of DNA). When a child clearly has symptoms of Canavan disease but standard diagnostic tests do not find both variants, doctors may recommend advanced methods like whole-exome sequencing or long-read sequencing to find the specific genetic changes [10][11].

What This Means for Your Family

Once your child’s exact ASPA variants are identified, this information is crucial for the rest of the family. The specific variant does not perfectly predict your child’s disease severity—care is guided by their actual symptoms rather than their genetic test results.

However, knowing the exact variant means that your extended relatives (such as adult siblings, aunts, uncles, and cousins) can undergo testing for your family’s exact variants if they are planning a pregnancy. A genetic counselor can help guide which family members might benefit from this testing.

Common questions in this guide

Can a child have Canavan disease if neither parent is Ashkenazi Jewish?
Yes. Canavan disease can occur in people of any ethnic background because it is caused by inheriting a disease-causing ASPA variant from each biological parent. Ashkenazi Jewish ancestry is associated with a higher carrier frequency, but it is not required.
How can healthy parents have a child with Canavan disease?
Most ASPA carriers are healthy and do not know they carry a variant. If both parents carry a disease-causing variant, a child can inherit one from each parent and have Canavan disease.
What is the chance of Canavan disease in another pregnancy?
When both biological parents carry a pathogenic ASPA variant, each pregnancy has a 25% chance of Canavan disease, a 50% chance of a child who is a healthy carrier, and a 25% chance of a child who has neither the disease nor a variant. These chances apply independently to each pregnancy, and a genetic counselor can review reproductive options.
Can carrier screening miss the ASPA variant in our family?
Yes. Targeted panels may look mainly for variants common in particular populations and may miss a rare or population-specific ASPA variant. Once your child’s variants are known, relatives can ask their clinician or genetic counselor whether family-specific testing or broader screening is appropriate.
What testing can find Canavan disease when standard ASPA testing is inconclusive?
Diagnostic testing often includes sequencing the full ASPA gene. If symptoms strongly suggest Canavan disease but standard testing does not identify both variants, clinicians may consider whole-exome or long-read sequencing to look for changes such as structural insertions.
Does consanguinity cause Canavan disease?
No. Having parents who are related can increase the chance that both carry the same rare ASPA variant, but consanguinity does not cause the disease by itself. Canavan disease also occurs in children of unrelated parents who both carry ASPA variants.
Can the specific ASPA variants predict how severe our child’s Canavan disease will be?
Not perfectly. The exact variants can help confirm the diagnosis and guide testing of relatives, but care is based mainly on the child’s actual symptoms and needs.

Get notified when new evidence is published on Canavan disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Homozygous Paternally Inherited ASPA Variant in a Patient with Canavan Disease.

    Yalcintepe S, Maras T, Kizilyar I, et al.

    Molecular syndromology 2024; (15(4)):284-288 doi:10.1159/000536386.

    PMID: 39119446
  2. 2

    Canavan Disease: Clinical and Laboratory Profile from Southern Part of India.

    Gowda VK, Bharathi NK, Bettaiah J, et al.

    Annals of Indian Academy of Neurology 2021; (24(3)):347-350 doi:10.4103/aian.AIAN_386_20.

    PMID: 34446995
  3. 3

    Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population.

    Rivas MA, Avila BE, Koskela J, et al.

    PLoS genetics 2018; (14(5)):e1007329 doi:10.1371/journal.pgen.1007329.

    PMID: 29795570
  4. 4

    Canavan disease: an Arab scenario.

    Zayed H

    Gene 2015; (560(1)):9-14.

    PMID: 25668701
  5. 5

    The natural history of Canavan disease: 23 new cases and comparison with patients from literature.

    Bley A, Denecke J, Kohlschütter A, et al.

    Orphanet journal of rare diseases 2021; (16(1)):227 doi:10.1186/s13023-020-01659-3.

    PMID: 34011350
  6. 6

    Novel mutation in an Egyptian patient with infantile Canavan disease.

    Zaki OK, El Abd HS, Mohamed SA, Zayed H

    Metabolic brain disease 2016; (31(3)):573-7 doi:10.1007/s11011-015-9772-z.

    PMID: 26613958
  7. 7

    Sequence variants in three genes underlying leukodystrophy in Pakistani families.

    Bibi F, Haider N, Din SU, et al.

    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 2020; (80(5)):380-388 doi:10.1002/jdn.10036.

    PMID: 32403196
  8. 8

    Prevalence and carrier frequency of Canavan disease in a South Indian community with implications for research and public health.

    Aaron R, Chapla A, Jayaprabha M, et al.

    Scientific reports 2026; (16(1)).

    PMID: 42143119
  9. 9

    Clustering of Juvenile Canavan disease in an Indian community due to population bottleneck and isolation: genomic signatures of a founder event.

    Kotambail A, Selvam P, Muthusamy K, et al.

    European journal of human genetics : EJHG 2023; (31(1)):73-80 doi:10.1038/s41431-022-01198-4.

    PMID: 36202930
  10. 10

    Deep Intronic SVA_E Insertion Identified as the Most Common Pathogenic Variant Associated With Canavan Disease: A Diagnostic Blind Spot.

    Dominguez Gonzalez CA, Bell KM, Rajagopalan R, et al.

    Neurology. Genetics 2025; (11(5)):e200291 doi:10.1212/NXG.0000000000200291.

    PMID: 40995055
  11. 11

    Aspartoacylase (ASPA) gene mutations and neuroimaging features in Iranian patients with Canavan disease: a descriptive study.

    Rahimian E, Tahsini MR, Karimzadeh P, et al.

    Brain & development 2026; (48(4)):104564 doi:10.1016/j.braindev.2026.104564.

    PMID: 42330600

This page is for informational purposes only and does not constitute medical advice. Your child’s genetics team or genetic counselor should interpret ASPA results and discuss testing and pregnancy risks for your family.